Brazil moves to stay abreast of dengue diagnostics developments
This article was originally published in Clinica
Executive Summary
The Brazilian health ministry is putting the dissemination of information on diagnostics advances at the top of its agenda for tackling dengue, despite a huge fall in the number of cases so far this year. "From an epidemiological vigilance point of view, laboratories must be kept abreast of the latest diagnostic techniques," said the health ministry of one of the main reasons for hosting the International Course on Dengue Control and Prevention Management, held in Fortaleza, on August 15-26.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.